|
Hookipa Pharma Inc on Thursday said it is not going ahead with a bid for Poolbeg Pharma PLC. In a brief statement regarding a possible combination between the two firms, the US-listed biopharmaceutical company said ‘it does not intend to make an offer for Poolbeg.’ ‘Non-binding’ and ‘non-exclusive’ talks between the two firms were announced in early January. Under the proposed terms announced in January, shareholders in Poolbeg, the London-based clinical stage biopharmaceutical firm, would have received 0.03 Hookipa shares for each Poolbeg share. Shares in Poolbeg closed down 2.9% at 4.71 pence each in London on Thursday. Copyright 2025 Alliance News Ltd. All Rights Reserved.
|
